{'fraction_non_alphanumeric': 0.04815864022662889, 'fraction_numerical': 0.05524079320113314, 'mean_word_length': 4.8429752066115705, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
71% of patients with newly diagnosed chronic kidney disease progressed to renal replacement therapy or death within 3 years

Patients: 920 patients 18–74 years of age (18% ,45 y, 41% 45–64 y, and 41% >65 y; 65% men) diagnosed with significant CKD (serum creatinine concentration .3.4 mg/dl [300 mmol/l] in men or .2.8 mg/dl [250 mmol/l] in women for the first time and permanently during the inclusion period), identified from the records of 68 medical laboratories that covered most inpatient and outpatient care in Sweden over a 2 year period. Patients with kidney transplants or elevated creatinine concentrations because of dehydration, acute renal failure, or terminal malignant disease were excluded.